Optical Coherence Tomography Angiography and Pseudophakic Cystoid Edema

Federico II University25 enrolled

Overview

This study evaluates the retinal vascular features in macula and papillary regions in patients affected by pseudophakic cystoid edema using optical coherence tomography angiography

Pseudophakic cystoid edema represents one of the most common causes of poor visual outcome following cataratta surgery. It is still source of debate the pathogenesis of Pseudophakic cystoid edema. Optical coherence tomography angiography represents a novel and non-invasive diagnostic technique that allows a detailed analysis of retinal vascular features. The study evaluates retrospectively the changes in optical coherence tomography angiography parameters at baseline and after three monthly after surgery.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pseudophakic Cystoid Macular Edema

Interventions

OCTA and pseudophakin cystoid edemaDIAGNOSTIC_TEST

Patients underwent OCT angiografia after cataract surgery

Eligibility

Sex: ALLMin age: 60 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age older than 60 years * diagnosis of pseudophakic cystoid macular oedema * treatment-naïve for pseudophakic cystoid macular oedema * absence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration) Exclusion Criteria: * age younger than 60 years * No diagnosis of pseudophakic cystoid macular oedema * previous treatment for pseudophakic cystoid macular oedema * presence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration)

Outcomes

Primary Outcomes

OCTA and pseudophakic cystoid macular oedema

The parameters analyzed by OCTA three months after surgery are: Vessel density (%) of superficial capillary plexus, deep capillary plexus, coriocapillary plexus in macular region Vessel density (%) of radial peripapillary capillary plexus in papilllary region

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.